Percutaneous radiofrequency thermal ablation of primary and metastatic hepatic tumors: Current concepts and review of the literature

Seminars in Interventional Radiology

Volumn 23, Issue 1, 2006, Pages 73-84

  Venkatesan, Aradhana M ^a   Gervais, Debra A ^a   Mueller, Peter R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Colorectal metastasis; Hepatocellular carcinoma; Liver; Neuroendocrine metastasis; Radiofrequency ablation

Indexed keywords

CANCER SURGERY; COLORECTAL CANCER; COMORBIDITY; FOLLOW UP; HUMAN; IMAGING SYSTEM; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER TRANSPLANTATION; LIVER TUMOR; MEDICAL LITERATURE; MINIMALLY INVASIVE SURGERY; MORBIDITY; NEUROENDOCRINE TUMOR; OUTPATIENT; PATIENT SELECTION; PRIMARY HEALTH CARE; RADIOFREQUENCY ABLATION; REVIEW; SURGICAL MORTALITY; TUMOR LOCALIZATION;

EID: 33646097444     PISSN: 07399529     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-939843     Document Type: Review

References (65)

1. Bentrem DJ, DeMatteo RP, Blumgart LH. Surgical therapy for metastatic disease to the liver. Annu Rev Med 2005;56:139-156
2. Curley SA, Marra P, Beaty K, et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 2004;239:450-458
3. Farmer DG, Rosve MH, Shaked A, et al. Current treatment modalities for hepatocellular carcinomas. Ann Surg 1994;219:236-247
4. Fong Y, Blumgart LH, Cohen AM. Surgical treatment of colorectal metastases to the liver. CA Cancer J Clin 1995;45:50-62
5. Fong Y, Kemedy N, Paty P, et al. Treatment of colorectal cancer: hepatic metastases. Semin Surg Oncol 1996;12:219-252
6. Franco D, Capussotti L, Smadja C, et al. Resection of hepatocellular carcinoma: results in 72 European patients with cirrhosis. Gastroenterology 1990;98:733-738
7. Bismuth H, Majno PE. Hepatobiliary surgery. J Hepatol 2000;32:208-224
8. Calvet X, Bruix J, Bru C, et al. Natural history of hepatocellular carcinoma in Spain: five year's experience in 249 cases. J Hepatol 1990;10:311-317
9. Ikeda K, Saitoh S, Koida I, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993;18:47-53
10. Rhim H, Goldberg SN, Dodd GD, et al. Essential techniques for successful radiofrequency thermal ablation of malignant hepatic tumors. Radiographics 2001;21:S17-S39
11. Gillams AR. The use of radiofrequency in cancer. Br J Cancer 2005;92:1825-1829
12. Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1000 cases. Cancer 2005;103:1201-1209
13. Parikh AA, Curley SA, Fornage BD, et al. RFA of hepatic metastases. Semin Oncol 2002;29:168-182
14. White TJ, Roy-Choudhury SH, Breen DJ, et al. Percutaneous radiofrequency ablation of colorectal hepatic metastases: initial experience. Dig Surg 2004;21:314-320
15. Choi D, Lim HK, Kim MJ, et al. Liver abscess after percutaneous radiofrequency ablation for hepatocellular carcinoma: frequency and risk factors. AJR Am J Roentgenol 2005;184:1860-1867
16. Dupuy DE, Goldberg SN. Image-guided radiofrequency tumor ablation: challenges and opportunities-part II. J Vasc Interv Radiol 2001;12:1135-1148
17. Rossi S, Garbagnati F, Lencioni R, et al. Percutaneous radiofrequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000;217:119-126
18. Choi D, Lim HK, Kim MJ, et al. Therapeutic efficacy and safety of percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the gastrointestinal tract. AJR Am J Roentgenol 2004;183:1417-1424
19. Yamakado K, Nakatsuka A, Akeboshi M, et al. Percutaneous radiofrequency ablation of liver neoplasms adjacent to the gastrointestinal tract after balloon catheter interposition. J Vasc Interv Radiol 2003;14:1183-1186
20. Chopra S, Dodd GD, Chanin MP, et al. Radiofrequency ablation of hepatic tumors adjacent to the gallbladder: feasibility and safety. AJR Am J Roentgenol 2003;180:697-701
21. Bilchik AJ, Wood TF, Allegra D, et al. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm. Arch Surg 2000;135:657-662
22. Onik G, Onik C, Medary I, et al. Life threatening hypertensive crises in two patients undergoing hepatic radiofrequency ablation. AJR Am J Roentgenol 2003;181:495-497
23. Bosch FX, Ribes J, Cleries R, et al. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005;9:191-211
24. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004;127:S27-S34
25. Lencioni R, Cioni D, Crocetti L, et al. Early stage hepatocellular carcinoma in patients with cirrhosis: long term results of percutaneous image-guided radiofrequency ablation. Radiology 2005;234:961-967
26. Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 2000;214:761-768
27. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for treatment of hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699
28. Ikeda K, Saitoh S, Tsubota A, et al. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 1993;71:19-25
29. Okada S, Shimada K, Yamamoto J, et al. Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 1994;106:1618-1624
30. Koike Y, Shiratori Y, Sato S, et al. Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus: an analysis of 236 consecutive patients with a single lesion. Hepatology 2000;32:1216-1223
31. Lu DS, Yu NC, Raman SS, et al. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology 2005;234:954-960
32. Lu DS, Yu NC, Raman SS. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 2005;41:1130-1137
33. American Cancer Society. Colorectal Cancer Facts and Figures, Special Edition. Atlanta, GA: American Cancer Society; 2005:1-22
34. Gillams AR, Lees WR. Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 2004;14:2261-2267
35. Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 1986;100:278-284
36. Solbiati L, Livraghi T, Goldbert SG, et al. Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer: long term results in 117 patients. Radiology 2001;221:159-166
37. LeVeen RF. Laser hyperthermia and radiofrequency ablation of hepatic lesions. Semin Intervent Radiol 1997;14:313-324
38. Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999;341:2039-2048
39. Bloomston M, Binitie O, Fraiji E, et al. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy. Am Surg 2002;68:827-831
40. Livraghi T, Solbiati L, Meloni F, et al. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection, the "test of time" approach. Cancer 2003;97:3027-3035
41. Gillams AR, Lees WR. RFA of CRC in 167 patients. Eur Radiol 2004;14:2261-2267
42. Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997;15:938-994
43. Oshowo A, Gillams A, Harrison E, et al. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg 2003;90:1240-1243
44. Berber E, Pelley R, Siperstein AE. Predictors of survival after radiofrequency ablation of colorectal cancer metastasis: a prospective study. J Clin Oncol 2005;23:1358-1364
45. Berber E, Flesher N, Siperstein AE. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases. World J Surg 2002;26:985-990
46. Oberg K. The use of chemotherapy in the management of neuroendocrine tumors. Endocrinol Metab Clin North Am 1993;22:941-952
47. Siperstein AE, Berber E. Cryoablation, percutaneous alcohol injection, and radiofrequency ablation for treatment of neuroendocrine liver metastases. World J Surg 2001;25:693-696
48. Siperstein A, Garland A, Engle K, et al. Laparoscopic radiofrequency ablation of primary and metastatic liver tumors: technical considerations. Surg Endosc 2000;14:400-405
49. Elvin A, Skogseid B, Hellman P. Radiofrequency ablation of neuroendocrine liver metastases. Abdom Imaging 2005;30:427-434
50. Elias D, Lasser PH, Montucolli D, et al. Hepatectomy for liver metastases from breast cancer. Eur J Surg Oncol 1995;21:510-523
51. Schneebaum S, Walker MJ, Young D, et al. The regional treatment of liver metastases from breast cancer. J Surg Oncol 1994;55:26-31
52. Livraghi T, Goldbert SN, Solbiati L, et al. Percutaneous radiofrequency ablation of liver metastases from breast cancer: initial experience in 24 patients. Radiology 2001;220:145-149
53. Burke DR, Lewis CA, Cardella JF, et al. Quality improvement guidelines for percutaneous transhepatic cholangiography and biliary drainage. Society of Cardiovascular and Interventional Radiology. J Vasc Interv Radiol 1997;8:677-681
54. Lewis CA, Allen TE, Burke DR, et al. Quality improvement guidelines for central venous access: the Standards of Practice Committee of the Society of Cardiovascular and Interventional Radiology. J Vasc Interv Radiol 1997;8:475-479
55. Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous radiofrequency ablation: complications encountered in a multicenter study. Radiology 2003;226:441-451
56. Curley SA, Marra P, Beaty K, et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 2004;239:450-458
57. Mulier S, Mulier P, Ni Y, et al. Complications of radiofrequency coagulation of liver tumors. Br J Surg 2002;89:1206-1222
58. Fisher RA, Maluf D, Cotterell AH, et al. Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list. Clin Transplant 2004;18:502-512
59. Goldberg SN, Gazelle SG, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques and diagnostic imaging guidance. AJR Am J Roentgenol 2000;174:323-331
60. McGhana JP, Dodd GD III. Radiofrequency ablation of the liver: current status. AJR Am J Roentgenol 2001;176:3-16
61. Dodd GD III, Soulen M, Kane R, et al. Minimally invasive treatment of malignant hepatic tumors: at the threshold of major breakthrough. Radiographics 2000;20:9-27
62. Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radiofrequency energy. Radiology 2000;217:633-646
63. Rossi S, DiStasi M, Buscarini E, et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 1996;167:759-768
64. Solbiati L, Goldbert SN, Ierace T, et al. Hepatic metastases: percutaneous radiofrequency ablation with cool-tip electrodes. Radiology 1997;205:367-373
65. Rhim H, Dodd GD III. Radiofrequency thermal ablation of liver tumors. J Clin Ultrasound 1999;27:221-229